Retirement Systems of Alabama Buys 35,974 Shares of Sotera Health Company $SHC

Retirement Systems of Alabama raised its stake in shares of Sotera Health Company (NASDAQ:SHC) by 16.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 248,899 shares of the company’s stock after purchasing an additional 35,974 shares during the period. Retirement Systems of Alabama’s holdings in Sotera Health were worth $4,391,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Nordea Investment Management AB bought a new position in shares of Sotera Health during the 4th quarter valued at about $1,908,000. Exchange Traded Concepts LLC bought a new position in shares of Sotera Health in the 4th quarter valued at about $7,739,000. Hudson Bay Capital Management LP bought a new position in shares of Sotera Health in the 3rd quarter valued at about $3,932,000. Voss Capital LP lifted its holdings in shares of Sotera Health by 50.0% in the 2nd quarter. Voss Capital LP now owns 750,000 shares of the company’s stock valued at $8,340,000 after acquiring an additional 250,000 shares during the last quarter. Finally, CenterBook Partners LP bought a new position in shares of Sotera Health in the 3rd quarter valued at about $1,228,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Sotera Health stock opened at $14.87 on Tuesday. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. Sotera Health Company has a 1-year low of $9.53 and a 1-year high of $19.85. The firm has a market capitalization of $4.23 billion, a P/E ratio of 55.08 and a beta of 1.88. The company’s 50-day moving average is $15.77 and its 200 day moving average is $16.52.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The company had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. During the same period in the prior year, the company posted $0.21 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Research analysts forecast that Sotera Health Company will post 0.61 EPS for the current year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the sale, the director directly owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. This represents a 43.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 47.55% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

SHC has been the subject of a number of analyst reports. Citigroup increased their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Zacks Research downgraded shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Finally, Royal Bank Of Canada initiated coverage on shares of Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price target for the company. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Sotera Health currently has an average rating of “Moderate Buy” and an average price target of $20.43.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.